secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-12-31T23:59:59+00:00
Accession:  0001213900-24-114021
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CERO Therapeutics issues ~84M new common shares and 8.4M warrants in December capital actions
--------------------------------------------------------------------------------

- From Dec 6-26, ~2,600 Series A and 213 Series B preferred shares converted into ~68M common shares.
- Issued 8.4M warrants at $0.0561/share to institutional investors on Dec 23 as condition to warrant exercises.
- Equity line issued ~16M common shares for ~$700k cash proceeds Dec 6-30.
- Preferred warrants exercised: 962 warrants for $962k stated value, netting $769.6k cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024114021/0001213900-24-114021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024114021/ea0226496-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-114021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer